Epirubicin hydrochloride
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Epirubicin hydrochloride, covering 2013-08-02 to 2022-02-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients [Phase 3]